目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.1.2.1 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 RESEARCH LIMITATIONS
2.5 GROWTH RATE ASSUMPTIONS
2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 METAGENOMIC SEQUENCING MARKET OVERVIEW
4.2 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY & COUNTRY (2021)
4.3 METAGENOMIC SEQUENCING MARKET SHARE FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Continuous technological innovations in NGS platforms
5.2.1.1.1 iSeq 100 System
5.2.1.1.2 Ion GeneStudio S5
5.2.1.2 Initiatives and funding from government & private bodies for large-scale sequencing projects
5.2.1.3 Declining costs of genome sequencing
5.2.1.4 Significant applications of metagenomics in various fields
5.2.2 RESTRAINTS
5.2.2.1 End-user budget constraints in developing countries
5.2.3 OPPORTUNITIES
5.2.3.1 NGS data analysis using big data
5.2.4 CHALLENGES
5.2.4.1 Challenges associated with metagenomic NGS
5.4 PORTER’S FIVE FORCES ANALYSIS
5.4.1 THREAT OF NEW ENTRANTS
5.4.2 THREAT OF SUBSTITUTES
5.4.3 BARGAINING POWER OF SUPPLIERS
5.4.4 BARGAINING POWER OF BUYERS
5.4.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
5.5 VALUE CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
5.7 PATENT ANALYSIS
5.7.1 TOP 10 GRANTED PATENT OWNERS IN THE LAST 20 YEARS
5.7.2 TOP 10 PLAYERS WITH THE HIGHEST NO. OF PATENT APPLICATIONS
5.7.3 LIST OF RECENT PATENTS
5.8 SUPPLY CHAIN ANALYSIS
5.9 REGULATORY ANALYSIS
5.9.1 NORTH AMERICA
5.9.1.1 US
5.9.1.2 Canada
5.9.2 EUROPE
5.9.3 ASIA PACIFIC
5.9.3.1 China
5.9.3.2 Japan
5.9.3.3 India
5.9.4 LATIN AMERICA
5.9.5 MIDDLE EAST
5.10 PRICING ANALYSIS
5.11 RANGES/SCENARIOS
5.12 TRADE ANALYSIS
5.12.1 TRADE ANALYSIS FOR METAGENOMIC SEQUENCING MARKET
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.14 KEY CONFERENCES & EVENTS, 2022
5.15 KEY STAKEHOLDERS & BUYING CRITERIA

6 METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
6.2 REAGENTS & CONSUMABLES
6.2.1 RISING ADOPTION OF METAGENOMIC SEQUENCING IS DRIVING THE USE OF REAGENTS & CONSUMABLES
6.3 INSTRUMENTS
6.3.1 LAUNCH OF ADVANCED NGS PLATFORMS WILL SUPPORT THE GROWTH OF THIS SEGMENT
6.4 SERVICES
6.4.1 TIME AND COST-EFFECTIVENESS OF OUTSOURCING NGS PROJECTS HAS DRIVEN THE DEMAND FOR SERVICES
6.5 ANALYSIS & DATA INTERPRETATION SOLUTIONS
6.5.1 LIMITED TECHNICAL KNOWLEDGE OF ADVANCED ANALYSIS SOLUTIONS AMONG END USERS TO HAMPER MARKET GROWTH

7 METAGENOMIC SEQUENCING MARKET, BY WORKFLOW (Page No. - 79)
7.1 INTRODUCTION
7.2 SAMPLE PROCESSING & LIBRARY PREPARATION
7.2.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED SAMPLE PROCESSING AND LIBRARY PREPARATION ASSAY KITS IS DRIVING MARKET GROWTH
7.3 SEQUENCING
7.3.1 SANGER SEQUENCING HAS BEEN SUPPLANTED BY NGS DUE TO ITS ADVANTAGES AND RAPIDITY
7.4 DATA PROCESSING & ANALYSIS
7.4.1 NEED FOR SKILLED PERSONNEL TO OPERATE DATA PROCESSING AND ANALYTICS TOOLS HAS SLOWED MARKET GROWTH

8 METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY (Page No. - 87)
8.1 INTRODUCTION
8.2 16S RRNA SEQUENCING
8.2.1 16S RRNA SEQUENCING IS A COST-EFFECTIVE TECHNIQUE FOR THE IDENTIFICATION OF BACTERIAL STRAINS
8.3 SHOTGUN METAGENOMIC SEQUENCING
8.3.1 SHOTGUN METAGENOMIC SEQUENCING SEGMENT TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
8.4 WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY
8.4.1 WGS HELPS GENERATE ACCURATE REFERENCE GENOMES FOR MICROBIAL IDENTIFICATION
8.5 METATRANSCRIPTOMICS
8.5.1 METATRANSCRIPTOMICS HELPS IN THE UNDERSTANDING OF THE ACTIVE FUNCTIONAL PROFILE OF A MICROBIAL COMMUNITY

9 METAGENOMIC SEQUENCING MARKET, BY APPLICATION (Page No. - 97)
9.1 INTRODUCTION
9.2 DRUG DISCOVERY
9.2.1 DRUG DISCOVERY ACCOUNTS FOR THE LARGEST SHARE OF THE METAGENOMIC SEQUENCING MARKET
9.3 CLINICAL DIAGNOSTICS
9.3.1 ADVANTAGES OF METAGENOMIC NGS HAVE ENABLED WIDE APPLICATIONS IN DIAGNOSTICS
9.4 SOIL MICROBIOME APPLICATIONS
9.4.1 NORTH AMERICA SHOWS HIGH DEMAND FOR METAGENOMIC SEQUENCING IN SOIL MICROBIOME APPLICATIONS
9.5 INDUSTRIAL APPLICATIONS
9.5.1 ENERGY
9.5.1.1 Declining fossil fuel reserves and growing energy needs will drive market growth
9.5.2 BIOREMEDIATION
9.5.2.1 Need to monitor pollutant impact and contamination will provide opportunities for metagenomic sequencing in bioremediation
9.5.3 OTHER INDUSTRIAL APPLICATIONS
9.6 ECOLOGICAL & ENVIRONMENTAL APPLICATIONS
9.6.1 METAGENOMIC SEQUENCING CAN HELP IDENTIFY INVASIVE AND ENDANGERED SPECIES
9.7 VETERINARY APPLICATIONS
9.7.1 DEMAND FOR RAPID AND ACCURATE PATHOGEN DIAGNOSIS IS SUPPORTING THE DEMAND FOR SEQUENCING
9.8 OTHER APPLICATIONS

10 METAGENOMIC SEQUENCING MARKET, BY REGION (Page No. - 116)
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.1.1 Well-established infrastructure and funding sources available for NGS-based small- and medium-sized research projects make the US the largest market in North America
10.2.2 CANADA
10.2.2.1 Increasing government initiatives and workshops to support growth in this market
10.3 EUROPE
10.3.1 GERMANY
10.3.1.1 Germany has witnessed a significant increase in investments in next-generation technologies, making it the largest market in Europe
10.3.2 FRANCE
10.3.2.1 Government initiatives to support genomics research drive growth in the metagenomic sequencing market in France
10.3.3 UK
10.3.3.1 Favorable funding scenario for genomics research in the country to support the adoption of NGS
10.3.4 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 CHINA
10.4.1.1 Several key market players are focusing on strengthening their presence and offerings in China—a key factor driving market growth
10.4.2 JAPAN
10.4.2.1 Rising use of metagenomic sequencing for various applications to drive market growth in Japan
10.4.3 INDIA
10.4.3.1 Increasing adoption of strategies such as collaborations and partnerships by various private and government bodies to drive market growth
10.4.4 REST OF ASIA PACIFIC
10.4.5 LATIN AMERICA
10.4.5.1 Introduction of low-cost sequencing technologies is expected to drive the market
10.4.6 MIDDLE EAST & AFRICA
10.4.6.1 Rising awareness of advanced sequencing technologies is expected to drive market growth in the coming years

11 COMPETITIVE LANDSCAPE (Page No. - 161)
11.1 KEY PLAYER STRATEGIES
11.2 MARKET SHARE ANALYSIS
11.3 REVENUE ANALYSIS
11.4 COMPANY EVALUATION QUADRANT
11.4.1 STARS
11.4.2 PERVASIVE PLAYERS
11.4.3 EMERGING LEADERS
11.4.4 PARTICIPANTS
11.5 COMPETITIVE LEADERSHIP MAPPING (START-UPS)
11.5.1 PROGRESSIVE COMPANIES
11.5.2 STARTING BLOCKS
11.5.3 DYNAMIC COMPANIES
11.5.4 RESPONSIVE COMPANIES
11.6 COMPETITIVE BENCHMARKING
11.7 COMPETITIVE SCENARIO
11.7.1 PRODUCT LAUNCHES
11.7.2 DEALS
11.7.3 OTHER DEVELOPMENTS

12 COMPANY PROFILES (Page No. - 173)
12.1 MAJOR PLAYERS
12.1.1 ILLUMINA, INC.
12.1.1.1 Business overview
12.1.1.2 Products & services offered
12.1.1.3 Recent developments
12.1.1.4 MnM view
12.1.2 THERMO FISHER SCIENTIFIC, INC.
12.1.2.1 Business overview
12.1.2.2 Products & services offered
12.1.2.3 Recent developments
12.1.2.4 MnM view
12.1.3 QIAGEN N.V.
12.1.3.1 Business overview
12.1.3.2 Products offered
12.1.3.3 Recent developments
12.1.3.4 MnM view
12.1.4 PERKINELMER, INC.
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.4.3 Recent developments
12.1.5 OXFORD NANOPORE TECHNOLOGIES, PLC.
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.5.3 Recent developments
12.1.6 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.6.3 Recent developments
12.1.7 BGI GROUP
12.1.7.1 Business overview
12.1.7.2 Products & services offered
12.1.7.3 Recent developments
12.1.8 PSOMAGEN, INC.
12.1.8.1 Business overview
12.1.8.2 Services offered
12.1.8.3 Recent developments
12.1.9 EUROFINS SCIENTIFIC
12.1.9.1 Business overview
12.1.9.2 Services offered
12.1.10 BROOKS AUTOMATION, INC.
12.1.10.1 Business overview
12.1.10.2 Services offered
12.1.11 NOVOGENE CO., LTD.
12.1.11.1 Business overview
12.1.11.2 Services offered
12.1.11.3 Recent developments
12.1.12 ZYMO RESEARCH CORPORATION
12.1.12.1 Business overview
12.1.12.2 Products & services offered
12.1.12.3 Recent developments
12.1.13 TECAN TRADING AG
12.1.13.1 Business overview
12.1.13.2 Products & services offered
12.1.14 INTEGRAGEN SA
12.1.14.1 Business overview
12.1.14.2 Services offered
12.1.15 MICROSYNTH AG
12.1.15.1 Business overview
12.1.15.2 Services offered
12.1.16 DNASTAR, INC.
12.1.16.1 Business overview
12.1.16.2 Products offered
12.2 OTHER COMPANIES
12.2.1 COSMOSID, INC.
12.2.2 GENEXA AG
12.2.3 VARIGEN BIOSCIENCES CORPORATION
12.2.4 VERITAS GENETICS
12.2.5 SINGENE
12.2.6 METAGENOMI
12.2.7 COMPUTOMICS
12.2.8 IDBYDNA, INC.
12.2.9 INTACT GENOMICS, INC.

13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS